Trials that use: Risk difference
New to this method? Read the tutorial →
6,276 results
- HEROIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- HEROES-DCBIndependent statistical analysis of Lutonix or Inpact for tHE tReatment Of fEmeropopliteal Stenosis - Drug Coated Balloon: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Hestia2Independent statistical analysis of A Study to Assess the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell Disease: primary endpoint results, effect estimate with…
- hFLCTxIndependent statistical analysis of Human Fetal Liver Cell Transplantation in Chronic Liver Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01013194).
- HFSCSIndependent statistical analysis of High Frequency Stimulation Trials in Patients With Precision Spinal Cord Stimulator System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HH4Independent statistical analysis of Post-Discharge Smoking Cessation Strategies: Helping HAND 4: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03603496).
- HHHFA in COPD Patients, With Chronic Bronchitis: Complete Statistical AnalysisIndependent statistical analysis of HHHFA in COPD Patients, With Chronic Bronchitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03959982).
- HIDEIndependent statistical analysis of Safety and Cardiovascular Efficacy of Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Hidradenitis Suppurativa Phase 2b Study of Izokibep: Complete Statistical AnalysisIndependent statistical analysis of Hidradenitis Suppurativa Phase 2b Study of Izokibep: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05355805).
- Hidradenitis Suppurativa Wound Care: Complete Statistical AnalysisIndependent statistical analysis of Hidradenitis Suppurativa Wound Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04354012).
- High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin’s Lymphoma or Central Nervous System (CNS) Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population: Complete Statistical AnalysisIndependent statistical analysis of High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer: Complete Statistical AnalysisIndependent statistical analysis of High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- High Dose or High Dose Frequency Study of Alglucosidase Alfa: Complete Statistical AnalysisIndependent statistical analysis of High Dose or High Dose Frequency Study of Alglucosidase Alfa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00483379).
- High Dose Oxytocin Nasal Spray for Treatment of Tinnitus: Complete Statistical AnalysisIndependent statistical analysis of High Dose Oxytocin Nasal Spray for Treatment of Tinnitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04210310).
- High Purity Type I Collagen Based Skin Substitute Vs Dehydrated Human Amnion/Chorion Membrane in Treatment of DFUs: Complete Statistical AnalysisIndependent statistical analysis of High Purity Type I Collagen Based Skin Substitute Vs Dehydrated Human Amnion/Chorion Membrane in Treatment of DFUs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML: Complete Statistical AnalysisIndependent statistical analysis of High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00774046).
- High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Complete Statistical AnalysisIndependent statistical analysis of High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): primary endpoint results, effect estimate with confidence interval, sample-size…
- High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00349778).
- High-dose vs. Standard-dose Cephalexin for Cellulitis: Complete Statistical AnalysisIndependent statistical analysis of High-dose vs. Standard-dose Cephalexin for Cellulitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04471246).
- High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy: Complete Statistical AnalysisIndependent statistical analysis of Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03388619).
- HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- HIPCVAX-010SIndependent statistical analysis of Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- HiRTIndependent statistical analysis of Hyperglycemia in Renal Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01643382).
- Histologic Assessment of the Difference Between 18F-2-fluoro-2-deoxy_D-glucose Positron Emission Mammography(PEM) and Magnetic Resonance Imaging (MRI) of the Breast: Complete Statistical AnalysisIndependent statistical analysis of Histologic Assessment of the Difference Between 18F-2-fluoro-2-deoxy_D-glucose Positron Emission Mammography(PEM) and Magnetic Resonance Imaging (MRI) of the Breast: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Historical Case Record Survey of Visual Acuity Data From Patients With Leber’s Hereditary Optic Neuropathy (LHON): Complete Statistical AnalysisIndependent statistical analysis of Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- HITCHIndependent statistical analysis of Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- HIV and Kidney Function Study: Complete Statistical AnalysisIndependent statistical analysis of HIV and Kidney Function Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00905151).
- HIV Self Testing of Male Partners of Women in PMTCT: Complete Statistical AnalysisIndependent statistical analysis of HIV Self Testing of Male Partners of Women in PMTCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03484533).
- HIV Vaccine Trial in Thai Adults: Complete Statistical AnalysisIndependent statistical analysis of HIV Vaccine Trial in Thai Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00223080).
- HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02370160).
- HNSCCIndependent statistical analysis of Single-arm Study With Bimiralisib in Patients With HNSCC Harboring NOTCH1 Loss of Function Mutations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE): Complete Statistical AnalysisIndependent statistical analysis of Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02798471).
- HOMEIndependent statistical analysis of Improving Health Outcomes and Equity by Targeting Postpartum Mothers at Highest Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Home-based Delivery of the Contraceptive Implant in Postpartum Guatemalan Women: Complete Statistical AnalysisIndependent statistical analysis of Home-based Delivery of the Contraceptive Implant in Postpartum Guatemalan Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04005391).
- Home-based Digital Exercise Training Program to Improve Physical Function of Older Sepsis Survivors – HEAL Sepsis Trial: Complete Statistical AnalysisIndependent statistical analysis of Home-based Digital Exercise Training Program to Improve Physical Function of Older Sepsis Survivors - HEAL Sepsis Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Home-based Transcranial Direct Current Stimulation (tDCS) for Behavioral Symptoms in Alzheimer’s Disease and Related Dementias (ADRD): Complete Statistical AnalysisIndependent statistical analysis of Home-based Transcranial Direct Current Stimulation (tDCS) for Behavioral Symptoms in Alzheimer's Disease and Related Dementias (ADRD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Homeopathic Cold Medicine for Children: Complete Statistical AnalysisIndependent statistical analysis of Homeopathic Cold Medicine for Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00858494).
- HOP-2AIndependent statistical analysis of HOP-2A - Intratesticular Hormone Levels: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00756561).
- HOP-3Independent statistical analysis of HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00839319).
- HOPE-2-OLEIndependent statistical analysis of Open-label Extension of the HOPE-2 Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04428476).
- HORIZON 2Independent statistical analysis of A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- HORIZON IIIndependent statistical analysis of Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women: Complete Statistical AnalysisIndependent statistical analysis of Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01633814).
- Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Hospital Waterbirth Trial to Measure Maternal and Neonatal Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Hospital Waterbirth Trial to Measure Maternal and Neonatal Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05175599).